Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2025-12-25 @ 12:08 AM
NCT ID: NCT05447858
Eligibility Criteria: Inclusion Criteria: For employees: * Self-reported WRNP lasting at least 4 weeks * Current neck pain ≥ 3 on the numeric rating scale (Numeric Rating Scale (NRS), 0-10) * Working age, 18-65 y * Neck problems clinically verified by clinical examination to ensure study criteria are met * Answered the baseline questionnaire and attended the first intervention visit * Completed and signed informed consent, including approval, to contact their immediate supervisor regarding work adaptations. For managers: • Being a head/ manager of a dental clinic. Exclusion Criteria: Red flags and illness/injury that are contraindicated for or hinder exercise or may be confounding factors for the results including: * Known pregnancy * Cannot understand/communicate in Swedish and would be unable to understand information about the study or answer questionnaires. For blood samples (not wanting to participate does not constitute exclusion from the RCT), the following exclusion criteria are added: • Increased tendency to bleed and use of blood thinners. For the microdialysis subgroup (n=30), consecutively asked, 15 persons/group; not wanting to participate does not constitute exclusion from the RCT), the following exclusion criteria are added: * Cannot imagine refraining from anti-inflammatory drugs (NSAIDs) during the 2 days prior to microdialysis * Hypersensitivity
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT05447858
Study Brief:
Protocol Section: NCT05447858